Phibro Animal Health Corporation (PAHC)
Cash conversion cycle
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 98.53 | 109.17 | 112.77 | 109.68 | 110.64 | 115.71 | 122.39 | 130.41 | 132.33 | 144.68 | 139.22 | 139.06 | 140.49 | 140.24 | 145.42 | 138.50 | 132.08 | 116.23 | 126.94 | 132.63 |
Days of sales outstanding (DSO) | days | 62.23 | 60.81 | 57.70 | 56.98 | 62.15 | 58.32 | 58.13 | 55.12 | 64.97 | 62.99 | 59.14 | 60.19 | 64.32 | 61.93 | 57.65 | 56.83 | 57.70 | 67.60 | 66.17 | 64.93 |
Number of days of payables | days | 31.71 | 31.95 | 33.99 | 30.34 | 29.44 | 29.94 | 34.09 | 41.04 | 48.81 | 51.93 | 48.66 | 41.98 | 44.40 | 42.70 | 43.15 | 42.05 | 44.39 | 44.69 | 38.22 | 39.92 |
Cash conversion cycle | days | 129.06 | 138.04 | 136.48 | 136.32 | 143.35 | 144.09 | 146.43 | 144.48 | 148.49 | 155.74 | 149.71 | 157.28 | 160.41 | 159.47 | 159.91 | 153.27 | 145.39 | 139.14 | 154.89 | 157.63 |
June 30, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 98.53 + 62.23 – 31.71
= 129.06
The cash conversion cycle of Phibro Animal Health Corporation has fluctuated over the past few quarters, ranging from a low of 129.06 days to a high of 160.41 days. The cash conversion cycle represents the time it takes for a company to convert its investments in inventory and other resources into cash flows from sales.
A shorter cash conversion cycle indicates that the company is able to efficiently manage its working capital, while a longer cash conversion cycle may suggest inefficiencies in managing inventory, accounts receivable, and accounts payable.
In the most recent quarter, the cash conversion cycle decreased to 129.06 days, indicating an improvement in the company's ability to convert its resources into cash. However, it is essential for Phibro Animal Health Corporation to continue monitoring and managing its working capital effectively to ensure optimal cash flow and overall financial performance.
Peer comparison
Jun 30, 2024